SB 5594 — Concerning biosimilar medicines.
Congress · introduced 2025-01-30
AN ACT Relating to reducing prescription drug costs by eliminating barriers impeding access to biosimilar medicines;
Latest action: 2025-03-11 — 1st substitute bill substituted.
Sponsors
- Harris, Paul (R, WA-17) — sponsor · 2025-01-30
- Cleveland, Annette (D, WA-49) — cosponsor · 2025-01-30
- Hasegawa, Bob (D, WA-11) — cosponsor · 2025-01-30
- Shewmake, Sharon (D, WA-42) — cosponsor · 2025-01-30
Action timeline
- · senate — First reading, referred to Health & Long-Term Care.
- · senate — HLTC - Majority; 1st substitute bill be substituted, do pass.
- · senate — HLTC - Majority; 1st substitute bill be substituted, do pass.
- · senate — Passed to Rules Committee for second reading.
- · senate — Passed to Rules Committee for second reading.
- · senate — Placed on second reading by Rules Committee.
- · senate — Placed on second reading by Rules Committee.
- · senate — 1st substitute bill substituted.
- · senate — 1st substitute bill substituted.
- · senate — Floor amendment(s) adopted.
- · senate — Rules suspended. Placed on Third Reading.
- · senate — Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
- · senate — First reading, referred to Health Care & Wellness.
- · senate — By resolution, returned to Senate Rules Committee for third reading.
- · senate — By resolution, reintroduced and retained in present status.
- · senate — Rules Committee relieved of further consideration.
- · senate — Placed on third reading.
- · senate — Rules suspended.
- · senate — Returned to second reading for amendment.
- · senate — Floor amendment(s) adopted.
- · senate — Rules suspended. Placed on Third Reading.
- · senate — Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
- · senate — First reading, referred to Health Care & Wellness.
- · senate — HCW - Executive action taken by committee.
- · senate — HCW - Majority; do pass.
- · senate — Referred to Rules 2 Review.
- · senate — By resolution, returned to Senate Rules Committee for third reading.
Text versions
No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.
Connected on the graph
Inbound (4)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| 2025-01-30 | Cleveland, Annette | cosponsor_of_bill | — | cosponsor | sponsorship |
| 2025-01-30 | Harris, Paul | sponsor_of_bill | — | sponsor | sponsorship |
| 2025-01-30 | Hasegawa, Bob | cosponsor_of_bill | — | cosponsor | sponsorship |
| 2025-01-30 | Shewmake, Sharon | cosponsor_of_bill | — | cosponsor | sponsorship |
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Harris, Paul (R, state_upper WA-17) | sponsor | 0 | — | 5 |
| 2 | Cleveland, Annette (D, state_upper WA-49) | cosponsor | 0 | — | 1 |
| 3 | Hasegawa, Bob (D, state_upper WA-11) | cosponsor | 0 | — | 1 |
| 4 | Shewmake, Sharon (D, state_upper WA-42) | cosponsor | 0 | — | 1 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)
By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2025-01-30 · cosponsored by Cleveland, Annette (cosponsor) · sponsorship
- 2025-01-30 · cosponsored by Hasegawa, Bob (cosponsor) · sponsorship
- 2025-01-30 · cosponsored by Shewmake, Sharon (cosponsor) · sponsorship
- 2025-01-30 · sponsored by Harris, Paul (sponsor) · sponsorship